WM

William Martin Falstich

Active Director Director DIN 11635602
DIN 11635602 First appointment May 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About William Martin Falstich

William Martin Falstich is a Director at Zydus Hospira Oncology Private Limited (since 2026). The company operates in Pharma.

DIN 11635602
Primary Designation Director
Industry Pharma
First Appointment 28 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 May 2026

Directorship timeline

Open interactive timeline →
Zydus Hospira Oncology Private Limited
Premium access

Shareholding and investment profile for William Martin Falstich

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about William Martin Falstich

William Martin Falstich currently holds 1 directorship: Zydus Hospira Oncology Private Limited (Director, since 28 May 2026).

William Martin Falstich was first appointed on 28 May 2026 as Director at Zydus Hospira Oncology Private Limited.

The current boards of William Martin Falstich's companies include Andrew David Chatfield (Zydus Hospira Oncology Private Limited), Ganesh Narayan Nayak (Zydus Hospira Oncology Private Limited), Marius James Mc Nicholas (Zydus Hospira Oncology Private Limited), Nareshkumar Natvarlal Prajapati (Zydus Hospira Oncology Private Limited), Prashant Sharma (Zydus Hospira Oncology Private Limited), Rashminkumar Bipinchandra Shah (Zydus Hospira Oncology Private Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available